 | • レポートコード：MRC2-11QY02729 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は注意欠陥多動性障害（ADHD）薬のグローバル市場について調査・分析したレポートです。種類別（覚醒剤、非覚醒剤）市場規模、用途別（小児、青年、成人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別注意欠陥多動性障害（ADHD）薬の競争状況、市場シェア ・世界の注意欠陥多動性障害（ADHD）薬市場：種類別市場規模 2015年-2020年（覚醒剤、非覚醒剤） ・世界の注意欠陥多動性障害（ADHD）薬市場：種類別市場規模予測 2021年-2026年（覚醒剤、非覚醒剤） ・世界の注意欠陥多動性障害（ADHD）薬市場：用途別市場規模 2015年-2020年（小児、青年、成人） ・世界の注意欠陥多動性障害（ADHD）薬市場：用途別市場規模予測 2021年-2026年（小児、青年、成人） ・北米の注意欠陥多動性障害（ADHD）薬市場分析：米国、カナダ ・ヨーロッパの注意欠陥多動性障害（ADHD）薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの注意欠陥多動性障害（ADHD）薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の注意欠陥多動性障害（ADHD）薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの注意欠陥多動性障害（ADHD）薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Perdue Pharma、Johnson & Johnson、Janssen Pharmaceuticals, Inc.、Takeda、Glaxosmith Kline、Novartis、Celltech Group ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market
The global Attention Deficit Hyperactivity Disorder (ADHD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Scope and Market Size
Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder (ADHD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is segmented into
Stimulants
Non-Stimulants
Segment by Application, the Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is segmented into
Pediatric
Adolescent
Adults
Regional and Country-level Analysis
The Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Attention Deficit Hyperactivity Disorder (ADHD) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share Analysis
Attention Deficit Hyperactivity Disorder (ADHD) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Attention Deficit Hyperactivity Disorder (ADHD) Drugs business, the date to enter into the Attention Deficit Hyperactivity Disorder (ADHD) Drugs market, Attention Deficit Hyperactivity Disorder (ADHD) Drugs product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly
Perdue Pharma
Johnson & Johnson
Janssen Pharmaceuticals, Inc.
Takeda
Glaxosmith Kline
Novartis
Celltech Group
1 Study Coverage
1.1 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Product Introduction
1.2 Market Segments
1.3 Key Attention Deficit Hyperactivity Disorder (ADHD) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Growth Rate by Type
1.4.2 Stimulants
1.4.3 Non-Stimulants
1.5 Market by Application
1.5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Growth Rate by Application
1.5.2 Pediatric
1.5.3 Adolescent
1.5.4 Adults
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue 2015-2026
2.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales 2015-2026
2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Competitor Landscape by Players
3.1 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Manufacturers
3.1.1 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Manufacturers
3.2.1 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue in 2019
3.2.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Price by Manufacturers
3.4 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Attention Deficit Hyperactivity Disorder (ADHD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size by Type (2015-2020)
4.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020)
4.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Type (2015-2020)
4.1.3 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size by Application (2015-2020)
5.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020)
5.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Application (2015-2020)
5.1.3 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Price by Application (2015-2020)
5.2 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs by Country
6.1.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country
6.1.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Type
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs by Country
7.1.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country
7.1.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Type
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs by Region
8.1.1 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Region
8.1.2 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs by Country
9.1.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country
9.1.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Type
9.3 Central & South America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs by Country
10.1.1 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country
10.1.2 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.1.5 Eli Lilly Related Developments
11.2 Perdue Pharma
11.2.1 Perdue Pharma Corporation Information
11.2.2 Perdue Pharma Description and Business Overview
11.2.3 Perdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.2.5 Perdue Pharma Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Janssen Pharmaceuticals, Inc.
11.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
11.4.3 Janssen Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.4.5 Janssen Pharmaceuticals, Inc. Related Developments
11.5 Takeda
11.5.1 Takeda Corporation Information
11.5.2 Takeda Description and Business Overview
11.5.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.5.5 Takeda Related Developments
11.6 Glaxosmith Kline
11.6.1 Glaxosmith Kline Corporation Information
11.6.2 Glaxosmith Kline Description and Business Overview
11.6.3 Glaxosmith Kline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.6.5 Glaxosmith Kline Related Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description and Business Overview
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.7.5 Novartis Related Developments
11.8 Celltech Group
11.8.1 Celltech Group Corporation Information
11.8.2 Celltech Group Description and Business Overview
11.8.3 Celltech Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.8.5 Celltech Group Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drugs Products Offered
11.1.5 Eli Lilly Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Estimates and Projections by Region
12.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Attention Deficit Hyperactivity Disorder (ADHD) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Attention Deficit Hyperactivity Disorder (ADHD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Segments
Table 2. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Stimulants
Table 5. Major Manufacturers of Non-Stimulants
Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Drugs as of 2019)
Table 15. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Attention Deficit Hyperactivity Disorder (ADHD) Drugs Price (2015-2020) (USD/MT)
Table 18. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Attention Deficit Hyperactivity Disorder (ADHD) Drugs Product Type
Table 20. Date of International Manufacturers Enter into Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020) (K MT)
Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Share by Type (2015-2020)
Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Share by Type (2015-2020)
Table 26. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020) (K MT)
Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Share by Application (2015-2020)
Table 29. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country (2015-2020) (K MT)
Table 30. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020) (K MT)
Table 34. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020) (K MT)
Table 36. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country (2015-2020) (K MT)
Table 38. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020) (K MT)
Table 42. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020) (K MT)
Table 44. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country (2015-2020) (K MT)
Table 54. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020) (K MT)
Table 58. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020) (K MT)
Table 60. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application (2015-2020)
Table 69. Eli Lilly Corporation Information
Table 70. Eli Lilly Description and Major Businesses
Table 71. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Eli Lilly Product
Table 73. Eli Lilly Recent Development
Table 74. Perdue Pharma Corporation Information
Table 75. Perdue Pharma Description and Major Businesses
Table 76. Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Perdue Pharma Product
Table 78. Perdue Pharma Recent Development
Table 79. Johnson & Johnson Corporation Information
Table 80. Johnson & Johnson Description and Major Businesses
Table 81. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Recent Development
Table 84. Janssen Pharmaceuticals, Inc. Corporation Information
Table 85. Janssen Pharmaceuticals, Inc. Description and Major Businesses
Table 86. Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Janssen Pharmaceuticals, Inc. Product
Table 88. Janssen Pharmaceuticals, Inc. Recent Development
Table 89. Takeda Corporation Information
Table 90. Takeda Description and Major Businesses
Table 91. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Takeda Product
Table 93. Takeda Recent Development
Table 94. Glaxosmith Kline Corporation Information
Table 95. Glaxosmith Kline Description and Major Businesses
Table 96. Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Glaxosmith Kline Product
Table 98. Glaxosmith Kline Recent Development
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Major Businesses
Table 101. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Novartis Product
Table 103. Novartis Recent Development
Table 104. Celltech Group Corporation Information
Table 105. Celltech Group Description and Major Businesses
Table 106. Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Celltech Group Product
Table 108. Celltech Group Recent Development
Table 109. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Attention Deficit Hyperactivity Disorder (ADHD) Drugs Players
Table 127. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Customers List
Table 128. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Product Picture
Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Stimulants Product Picture
Figure 4. Non-Stimulants Product Picture
Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Pediatric
Figure 7. Adolescent
Figure 8. Adults
Figure 9. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Report Years Considered
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales 2015-2026 (K MT)
Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Region in 2019
Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Region in 2019
Figure 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue in 2019
Figure 19. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Type in 2019
Figure 22. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Type in 2019
Figure 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Application in 2019
Figure 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Application in 2019
Figure 29. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country in 2019
Figure 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Type in 2019
Figure 38. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Application in 2019
Figure 39. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country in 2019
Figure 42. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Type in 2019
Figure 54. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Region in 2019
Figure 59. China Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Application in 2019
Figure 83. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Type in 2019
Figure 94. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Share by Application in 2019
Figure 107. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
注意欠陥・多動性障害（ADHD）の世界市場（～2026年） Attention Deficit Hyperactivity Disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It may begin in early childhood and can continue into adulthood. Without treatment, ADHD can cause problem…- 注意欠陥・多動性障害（ADHD）治療薬の世界市場（～2026年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…
- ADHD治療薬の世界市場（～2026年） Market Analysis and Insights: Global ADHD Drugs Market The global ADHD Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global ADHD Drugs Scope and Market Size ADHD Drugs market is segmented by Type, and by Application. …
- 神経障害治療薬の世界市場（～2026年） Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively su…
- 胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年） Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities. Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually inc…